Geographic atrophy is an advanced form of dry age-related macular degeneration that causes vision loss in older adults. Until recently, there were no treatments available to target the root cause.

A Center for Eye Research Australia study has linked low levels of oxygen in the blood overnight—a common sign of obstructive ...

Prevent Blindness announces its fourth annual Geographic Atrophy Awareness Week, December 2 to 8, 2024. The organization ...

This eventually leads to a thinner RPE and eventually geographic atrophy: regions of dead cells. Though more work is needed, ...

Geographic atrophy, or GA, is an advanced form of age-related macular degeneration that can affect your daily activities and quality of life. In this video, we'll explore ways to find support and ...

Attendees participated in a diverse range of presentations on wet AMD, including discussions on advances in retinal imaging technology and the latest research on the management of macular atrophy ...

there was no treatment for geographic atrophy, which is an advanced form of dry macular degeneration. Dry macular ...

A recently approved C3 inhibitor for geographic atrophy may increase the risk of neovascular age-related macular degeneration, making it crucial for clinicians to try to identify the patients that ...

Syfovre (pegcetacoplan) is a prescription drug used to treat geographic atrophy caused by age-related macular degeneration. The drug is given as an intravitreal injection by your doctor.

Photodynamic therapy with verteporfin of CNV represents an advancement in the treatment of myopic macular degeneration complicated ... of chorioretinal atrophy. Limited macular translocation ...